Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
The Exchange had sought clarification from Nephro Care India Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the SEBI (Lis...more...
The Exchange has sought clarification from Nephro Care India Limited for the quarter ended 31-Dec-2025 with respect to Regulation 33 of the ...more...
Nephro Care India Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32more...
Nephro Care India Limited has informed the Exchange regarding Board meeting held on February 13 2026.more...
Nephro Care India Limited has submitted to the Exchange the financial results for the period ended December 31 2025.more...
SDD Certificate for the quarter ended 31st December 2025more...
Nephro Care India Limited has informed regarding Submission of the Compliance Report on Corporate Governance for the Q_ FY 20__-__more...
Nephro Care India Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations 2018more...
Nephro Care India Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulation...more...
Nephro Care India Limited has informed the Exchange related to incorporation of Subsidiary Companymore...
Nephro Care India Limited has informed the Exchange about General Updatesmore...
Nephro Care India Limited has informed the Exchange regarding a press release dated November 12 2025 titled Multi-speciality healthcare prov...more...
Nephro Care India Limited has submitted to the Exchange the financial results for the period ended September 30 2025.more...
Nephro Care India Limited has informed the Exchange about related Party Transactionsmore...
Nephro Care India Limited has informed the Exchange regarding Board meeting held on November 12 2025.more...
SDD Compliance Certificate for the quarter ended 30th September 2025more...
As of September 2025 61.47% is owned by Indian Promoters and 38.53% by Public. Top four Promoters holding highest number of shares of Nephro Care Ind...more...
Nephro Care India Limited has informed the Exchange about Certificate under regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018more...
BOARD MEETINGS Company Name : Biogen Pharmachem Date : 23-03-2026